These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10684886)

  • 1. Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats.
    Cai G; Zhen X; Uryu K; Friedman E
    J Neurosci; 2000 Mar; 20(5):1849-57. PubMed ID: 10684886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease.
    Zhen X; Torres C; Cai G; Friedman E
    Mol Pharmacol; 2002 Dec; 62(6):1356-63. PubMed ID: 12435803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
    Papadeas ST; Blake BL; Knapp DJ; Breese GR
    J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.
    Oh JD; Vaughan CL; Chase TN
    Brain Res; 1999 Mar; 821(2):433-42. PubMed ID: 10064831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 priming enhances both D1- and D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Thomas LI
    Pharmacol Biochem Behav; 2010 Jan; 94(3):346-51. PubMed ID: 19800912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.
    Brus R; Kostrzewa RM; Nowak P; Perry KW; Kostrzewa JP
    Neurotox Res; 2003; 5(5):329-38. PubMed ID: 14715452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2/MAP kinase.
    Gerfen CR; Miyachi S; Paletzki R; Brown P
    J Neurosci; 2002 Jun; 22(12):5042-54. PubMed ID: 12077200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhou LW; Zhang SP; Weiss B
    Neurochem Int; 1996 Dec; 29(6):583-95. PubMed ID: 9113126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats.
    Guo M; Xiang T; Li M; Sun Y; Sun S; Chen D; Jia Q; Li Y; Yao X; Wang X; Zhang X; He F; Wang M
    Behav Brain Res; 2021 Aug; 411():113339. PubMed ID: 33945831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
    Tseng KY; Riquelme LA; Belforte JE; Pazo JH; Murer MG
    Eur J Neurosci; 2000 Jan; 12(1):247-56. PubMed ID: 10651879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Strauss JB
    Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway.
    Brown P; Gerfen CR
    J Comp Neurol; 2006 Sep; 498(3):415-30. PubMed ID: 16871540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D(1) but not D(2) receptor agonists.
    Cauli O; Pinna A; Morelli M
    Behav Pharmacol; 2005 Dec; 16(8):621-6. PubMed ID: 16286813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.